炎症性肠病的治疗新进展  

New progress of treatment of inflammatory bowel disease

作　　者：王苗[1] 曲波[1] 李惠[1] 

机构地区：[1]哈尔滨医科大学附属第二医院消化内科,黑龙江哈尔滨150086

出　　处：《胃肠病学和肝病学杂志》2016年第7期736-738,共3页Chinese Journal of Gastroenterology and Hepatology

摘　　要：炎症性肠病(inflammatory bowel disease,IBD)是一种病因未明的慢性、反复性、肠道炎症性疾病。其常见的临床表现包括腹痛、腹泻及体质量下降等。其特点是病情易反复、药物治疗不理想,目前常用的药物治疗作用较局限,且副作用较多。随着对IBD发病机制越来越深入的研究,新的治疗方法及药物也不断被发现。本文就IBD新的治疗方法及药物作一概述。Inflammatory bowel disease （IBD） is a kind of chronic, recurrent, progressive bowel disorder diseases, and its etiology remains unclears. Its common clinical manifestations are abdominal pain, diarrhea, weight loss, and so on. Its characteristics are repeatedly diseased, poor medical treatment results. The current drugs used for IBD have some limitations and many side effects. With the further research on the pathogenesis of IBD, new treatments and drugs are also being discovered. In this paper, the progress of treatments and drugs of IBD was reviewed.

关 键 词：炎症性肠病 饮食治疗 干细胞移植 人参皂甙 疫苗 

分 类 号：R574.62[医药卫生—消化系统]